MedTrace Logo

Safety and Efficacy of Botulinum Toxin-A Injection Into Ischiocavernosus Muscle for Premature Ejaculation

NCT06851598 · Status: ACTIVE_NOT_RECRUITING · Phase: PHASE2/PHASE3 · Type: INTERVENTIONAL · Enrollment: 45

Last updated 2025-02-28

No results posted yet for this study

Summary

The aim of this work is to assess the efficacy and safety of Botulinum toxin - A injection into ischiocavernosus muscle in treatment of primary premature ejaculation.

Conditions

  • Premature Ejaculation

Interventions

DRUG

25 units botox

25 units of botox injection into ischiocavernosus muscle

DRUG

50 units Botox

50 Units botox injection into ischiocavernosus muscle

DRUG

75 units Botox

75 units botox injection into ischiocavernosus muscle

Sponsors & Collaborators

  • Abdallah Mohamed Abdallah Mohamed Elgendy

    lead OTHER

Principal Investigators

  • Abdelraouf Elmohsen, Professor · Dermatology, Venereology and Andrology Faculty of Medicine, Al-Azhar University

  • Ahmed Elshahid, Professor · Dermatology, Venereology and Andrology Faculty of Medicine, Al-Azhar University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
16 Years
Max Age
65 Years
Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-07-01
Primary Completion
2025-02-01
Completion
2025-03-01

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06851598 on ClinicalTrials.gov